GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,048,000 | -64.2% | 59,113 | -69.7% | 0.01% | -61.3% |
| Q4 2021 | $5,718,000 | -46.4% | 195,366 | -53.3% | 0.03% | -55.1% |
| Q3 2021 | $10,665,000 | -11.3% | 418,563 | +22.0% | 0.07% | -16.9% |
| Q2 2021 | $12,018,000 | +3.5% | 343,176 | +20.4% | 0.08% | -2.4% |
| Q1 2021 | $11,612,000 | -21.5% | 284,955 | -16.6% | 0.08% | -31.5% |
| Q4 2020 | $14,794,000 | +796.6% | 341,583 | +1041.4% | 0.12% | +785.7% |
| Q3 2020 | $1,650,000 | -46.0% | 29,926 | -22.1% | 0.01% | -76.7% |
| Q4 2019 | $3,054,000 | +63.0% | 38,423 | -1.0% | 0.06% | +36.4% |
| Q1 2018 | $1,874,000 | -43.9% | 38,806 | -57.2% | 0.04% | -45.7% |
| Q1 2017 | $3,341,000 | – | 90,655 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |